Novo Nordisk said it is on track to make Wegovy more widely available in December, and that a broad commercial re-launch is expected next year
Valsesia A, Rimoldi D, Martinet D, Ibberson M, Benaglio P, Quadroni M et al
Unlike standard pharmaceutical doses fixed at predetermined intervals, PlexusDx compounds support micro-dosing schedules that allow slower titration curves
The flushed appearance is often more prominent in those with lighter colored skin
That opened the market for a supply-chain contingency we pay way too little attention to: compounding
Their high receptor specificity and relatively low toxicity profiles (compared to small molecules or full-length proteins) have made them central to 21st-century drug discovery